Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II RCT of topical menthol gel vs placebo for chemotherapy-induced peripheral neuropathic pain
2013-003968-31Phase 2Unknown
- Sponsor
- University of Edinburgh
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chemotherapy-induced peripheral neuropathy (CIPN), Sensory neuropathy (SN) and Neuralgia comparing Topical 3% levomenthol gel with Topical placebo gel (2 arms). Primary endpoint: Primary analgesic response at 6 weeks. Status: unknown.
02
Drugs
l-Menthol
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)Sensory neuropathy (SN)Neuralgia
Beyond the preview
Go deeper on 2013-003968-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003968-31.